3/16
08:03 am
zvra
Zevra Therapeutics (ZVRA) is now covered by BTIG Research. They set a "buy" rating and a $23.00 price target on the stock.
Medium
Report
Zevra Therapeutics (ZVRA) is now covered by BTIG Research. They set a "buy" rating and a $23.00 price target on the stock.
3/16
06:43 am
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
3/16
06:38 am
zvra
Zevra Therapeutics initiated with a Buy at BTIG
Low
Report
Zevra Therapeutics initiated with a Buy at BTIG